Skip to content
10-Q

Quarterly Report

ENvue Medical, Inc. FEED

0001493152-25-023542

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 14, 2025 1.09M sh
Shares Diluted Q3 2025 · Sep 30, 2025 858.43K sh
Shares Diluted Q3 2025 · Sep 30, 2025 470.94K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 280.32K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 271.28K sh
Capex Q3 2025 · Sep 30, 2025 $37K
Capex Q3 2025 · Sep 30, 2024 $3K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$6.7M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$1.97M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $6.95M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $752K
Cash And Equivalents Q3 2025 · Sep 30, 2024 $1.31M
Stockholders Equity Q3 2025 · Sep 30, 2025 $42.46M
Stockholders Equity Q3 2025 · Jun 30, 2025 $40.48M
Stockholders Equity Q3 2025 · Dec 31, 2024 $627K
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.87M
Stockholders Equity Q3 2025 · Jun 30, 2024 $2.84M
Stockholders Equity Q3 2025 · Dec 31, 2023 $3.99M
Current Liabilities Q3 2025 · Sep 30, 2025 $11.64M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.72M
Total Liabilities Q3 2025 · Sep 30, 2025 $11.92M
Total Liabilities Q3 2025 · Dec 31, 2024 $3M
Current Assets Q3 2025 · Sep 30, 2025 $10.02M
Current Assets Q3 2025 · Dec 31, 2024 $3.33M
Total Assets Q3 2025 · Sep 30, 2025 $54.38M
Total Assets Q3 2025 · Dec 31, 2024 $3.63M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.91
Eps Diluted Q3 2025 · Sep 30, 2025 −$6.69
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$3.56
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$8.38
Eps Basic Q3 2025 · Sep 30, 2025 −$0.91
Eps Basic Q3 2025 · Sep 30, 2025 −$6.69
Eps Basic restated Q3 2025 · Sep 30, 2024 −$3.56
Eps Basic restated Q3 2025 · Sep 30, 2024 −$8.38
Sga Expense Q3 2025 · Sep 30, 2025 $1.4M
Sga Expense Q3 2025 · Sep 30, 2025 $5M
Sga Expense Q3 2025 · Sep 30, 2024 $673K
Sga Expense Q3 2025 · Sep 30, 2024 $2.34M
Rd Expense Q3 2025 · Sep 30, 2025 $221K
Rd Expense Q3 2025 · Sep 30, 2025 $1.72M
Rd Expense Q3 2025 · Sep 30, 2024 $249K
Rd Expense Q3 2025 · Sep 30, 2024 $557K
Net Income Q3 2025 · Sep 30, 2025 $510K
Net Income Q3 2025 · Sep 30, 2025 −$5.33M
Net Income Q3 2025 · Sep 30, 2024 −$998K
Net Income Q3 2025 · Sep 30, 2024 −$2.27M
Operating Income Q3 2025 · Sep 30, 2025 −$2.25M
Operating Income Q3 2025 · Sep 30, 2025 −$8.08M
Operating Income Q3 2025 · Sep 30, 2024 −$970K
Operating Income Q3 2025 · Sep 30, 2024 −$2.21M
Gross Profit Q3 2025 · Sep 30, 2025 $189K
Gross Profit Q3 2025 · Sep 30, 2025 $523K
Gross Profit Q3 2025 · Sep 30, 2024 $133K
Gross Profit Q3 2025 · Sep 30, 2024 $1.23M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $533K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.72M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $243K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $889K
Revenue Q3 2025 · Sep 30, 2025 $722K
Revenue Q3 2025 · Sep 30, 2025 $2.24M
Revenue Q3 2025 · Sep 30, 2024 $376K
Revenue Q3 2025 · Sep 30, 2024 $2.11M